PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 204 filers reported holding PTC THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $29,770 | -92.3% | 732 | -90.8% | 0.00% | -100.0% |
| Q1 2023 | $387,375 | -89.4% | 7,997 | -89.0% | 0.00% | -90.9% |
| Q3 2022 | $3,638,000 | +363700.0% | 72,477 | +329340.9% | 0.01% | – |
| Q1 2021 | $1,000 | -100.0% | 22 | -100.0% | 0.00% | -100.0% |
| Q4 2020 | $2,772,000 | +4940.0% | 45,419 | +3613.7% | 0.01% | – |
| Q1 2020 | $55,000 | -99.7% | 1,223 | -99.7% | 0.00% | -100.0% |
| Q4 2019 | $21,364,000 | +5322.3% | 444,803 | +3714.1% | 0.05% | +4700.0% |
| Q3 2019 | $394,000 | -50.6% | 11,662 | -60.4% | 0.00% | -50.0% |
| Q1 2018 | $797,000 | +4588.2% | 29,457 | +2831.0% | 0.00% | – |
| Q4 2017 | $17,000 | -66.7% | 1,005 | -60.6% | 0.00% | – |
| Q3 2017 | $51,000 | -32.0% | 2,551 | -37.6% | 0.00% | – |
| Q2 2017 | $75,000 | +38.9% | 4,085 | -25.9% | 0.00% | – |
| Q1 2017 | $54,000 | +390.9% | 5,511 | +466.4% | 0.00% | – |
| Q4 2016 | $11,000 | +1000.0% | 973 | +3792.0% | 0.00% | – |
| Q3 2016 | $1,000 | -99.2% | 25 | -99.9% | 0.00% | – |
| Q2 2016 | $118,000 | – | 16,868 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
| Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
| ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
| COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
| GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
| SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
| Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
| Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |